[시장보고서]지질 나노입자 시장 분석 및 예측 : 유형별, 제품 유형별, 기술별, 용도별, 재료 유형별, 프로세스별, 최종 사용자별, 기능별, 솔루션별(-2035년)

지질 나노입자 시장 분석 및 예측 : 유형별, 제품 유형별, 기술별, 용도별, 재료 유형별, 프로세스별, 최종 사용자별, 기능별, 솔루션별(-2035년)

Lipid Nanoparticles Market Analysis and Forecast to 2035: Type, Product, Technology, Application, Material Type, Process, End User, Functionality, Solutions

상품코드 : 1954279

리서치사 : Global Insight Services

발행일 : 2026년 02월

페이지 정보 : 영문 372 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,750

￦ 7,170,000

PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.

US $ 5,750

￦ 8,679,000

PDF & Excel (Site License)

PDF, Excel 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다.

US $ 6,750

￦ 10,189,000

PDF & Excel (Enterprise License)

PDF, Excel 보고서를 동일 기업의 전 세계 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF, Excel 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

지질 나노입자 시장은 2024년 14억 달러로 평가되었고, 2034년까지 43억 달러에 이르고, CAGR은 약 12.6%를 나타낼 것으로 예측됩니다. 지질 나노입자 시장은 특히 mRNA 백신 및 유전자 치료에서 약물 전달을 위한 나노스케일 지질 운반체의 개발과 응용을 포함합니다. 이들 나노입자는 치료제의 표적 전달 및 제어된 방출을 가능하게 하고, 효능을 증가시키면서 부작용을 감소시킵니다. 이 시장은 나노기술의 진보, 정밀의료에 대한 수요 증가, 지질 나노입자 기반의 COVID-19 백신의 성공에 의해 견인되고 있으며, 이 변혁적인 분야에서의 추가 연구개발과 투자를 촉진하고 있습니다.

지질 나노입자 시장은 약물전달 시스템과 백신 개발의 진보에 힘입어 견고한 성장을 이루고 있습니다. 의약품 분야가 가장 높은 성장률을 나타내고 있으며, mRNA 기반 치료제에서 지질 나노입자의 응용 확대가 견인 역할을 하고 있습니다. 이 분야 내에서 주로 지질 나노 입자 기반 COVID-19 백신의 성공으로 백신 전달 시스템이 주도적 역할을 담당하고 있습니다. 이어서 종양학 약물 전달 하위 부문이 계속되어, 표적화 능력의 향상과 부작용의 저감이라는 이점으로부터 혜택을 받고 있습니다. 화장품 산업은 2위의 성장 부문이며, 지질 나노입자는 성분의 안정성과 침투성을 향상시킴으로써 스킨케어 제형에 혁명을 가져옵니다. 특히 안티 에이징 크림이나 선스크린 등 퍼스널케어 제품에서 현저한 수요 증가를 볼 수 있습니다. 다양한 치료 용도를 위한 지질 나노입자 제제의 최적화에 초점을 맞춘 연구개발 활동이 활발해지고 있습니다. 유전자 치료와 맞춤형 의료에 대한 지질 나노입자의 통합은 유망한 기회로서 대두되고 있으며, 시장의 성장과 혁신을 더욱 촉진하고 있습니다.

시장 세분화
유형	고체 지질 나노 입자, 나노 구조 지질 운반체, 리포솜
제품	약물 전달 시스템, 화장품 제형, 영양 보조 식품, 유전자 치료 벡터
기술	고압 균질화, 마이크로에멀젼, 용매 증발, 초임계 유체 기술
용도	의약품, 화장품, 식품 및 음료, 생명공학
재료 유형	인지질, 콜레스테롤, 중성지방, 지방산
프로세스	캡슐화, 유화, 동결건조, 분무건조
최종 사용자	제약 회사, 화장품 제조 업체, 연구 기관, 식품 산업
기능성	방출 조절, 표적 전달, 생물학적 이용능력 향상, 안정성 개선
솔루션	맞춤형 제형 개발, 분석 서비스, 스케일업 및 제조, 규제 컨설팅

지질 나노입자 시장은 시장 점유율, 가격 전략, 제품 혁신의 현저한 변화를 특징으로 하는 역동적인 상황에 있습니다. 주요 기업은 제품 포트폴리오를 강화하기 위해 전략적 파트너십 및 협업에 주력하고 있습니다. 약물전달 시스템과 맞춤형 의료의 진보를 배경으로 신제품 출시가 급증하고 있습니다. 의약품 응용 분야에서 비용 효율적인 솔루션이 필요하기 때문에 가격 경쟁은 여전히 치열한 상황입니다. R&D에 중점을 둔 이니셔티브는 최고 기업간 경쟁 우위를 키우고 시장 성장을 가속하고 있습니다. 경쟁 벤치마킹은 여러 유력 기업들이 큰 영향력을 행사하는 집중 시장임을 밝혀 왔습니다. 지역별 규제 프레임 워크, 특히 북미와 유럽의 규제는 시장 역학을 형성하는 데 매우 중요합니다. 이러한 규정은 안전과 효과를 보장하며 제품 승인 및 시장 진입에 영향을 미칩니다. 경쟁 구도는 혁신이 특징이며, 각 회사는 시장에서의 지위를 유지하기 위해 최첨단 기술에 대한 투자를 진행하고 있습니다. 전략적 합병·인수가 널리 이루어지고, 능력과 시장 전개가 강화되고 있습니다. 바이오테크놀러지 및 제약 분야에서 수요 증가를 배경으로 시장은 성장의 기운이 높아지고 있습니다.

주요 동향과 촉진요인

지질 나노입자 시장은 나노기술의 진보와 표적형 약물전달 시스템에 대한 수요 증가를 배경으로 견고한 성장을 이루고 있습니다. 주요 동향은 mRNA 백신에 지질 나노입자의 통합을 포함하였으며, 이는 COVID-19 팬데믹에서 매우 중요한 역할을 했습니다. 이에 따라 제약기업이 혁신적인 제제와 전달 메커니즘에 주력하는 가운데 해당 분야의 조사와 투자가 가속화되고 있습니다. 또 다른 중요한 촉진요인은 효과적인 약물 전달 솔루션이 필요한 만성 질환의 유병률 증가입니다. 지질 나노입자는 생물학적 이용능력의 향상과 제어된 방출을 실현하기 때문에 다양한 질병의 치료에 이상적입니다. 또한 화장품 분야에서의 응용에 대한 관심도 높아지고 있으며, 지질 나노입자는 스킨케어 제품에서 유효성분의 전달을 강화합니다. 또한, 나노기술 조사에 대한 정부의 지원과 자금 제공이 시장 성장을 뒷받침하고 있습니다. 맞춤형 의료 분야에서는 환자의 개별 요구에 맞게 지질 나노입자를 조정할 수 있기 때문에 많은 기회가 존재합니다. 효율적이고 정밀한 약물 전달 시스템에 대한 수요가 계속 증가하고 있는 가운데 지질 나노입자 제제 최적화를 위한 R&D에 투자하는 기업은 큰 시장 점유율을 얻는 좋은 위치에 있습니다.

시장 규모 및 예측 : 유형별
- 고체 지질 나노입자
- 나노구조 지질 운반체
- 리포솜
시장 규모 및 예측 : 제품별
- 약물전달 시스템
- 화장품 제제
- 뉴트라슈티컬
- 유전자 치료 벡터
시장 규모 및 예측 : 기술별
- 고압 균질화
- 마이크로에멀젼
- 용매 증발
- 초임계 유체 기술
시장 규모 및 예측 : 용도별
- 의약품
- 화장품
- 식음료
- 생명공학
시장 규모 및 예측 : 소재 유형별
- 인지질
- 콜레스테롤
- 트리글리세라이드
- 지방산
시장 규모 및 예측 : 프로세스별
- 캡슐화
- 유화
- 동결건조
- 분무건조
시장 규모 및 예측 : 최종사용자별
- 제약기업
- 화장품 제조업체
- 연구기관
- 식품산업
시장 규모 및 예측 : 기능성별
- 방출 조절
- 표적화 전달
- 생물학적 이용능력 향상
- 안정성 향상
시장 규모 및 예측 : 솔루션별
- 커스텀 제형 개발
- 분석 서비스
- 스케일업 및 제조
- 인허가 컨설팅

제5장 지역별 분석

북미
- 미국
- 캐나다
- 멕시코
라틴아메리카
- 브라질
- 아르헨티나
- 기타 라틴아메리카
아시아태평양
- 중국
- 인도
- 한국
- 일본
- 호주
- 대만
- 기타 아시아태평양
유럽
- 독일
- 프랑스
- 영국
- 스페인
- 이탈리아
- 기타 유럽
중동 및 아프리카
- 사우디아라비아
- 아랍에미리트(UAE)
- 남아프리카
- 사하라 이남 아프리카
- 기타 중동 및 아프리카

제6장 시장 전략

수요 및 공급 격차 분석
무역 및 물류상의 제약
가격-비용-마진 추세
시장 침투
소비자 분석
규제 개요

제7장 경쟁 정보

시장 포지셔닝
시장 점유율
경쟁 벤치마킹
주요 기업의 전략

제8장 기업 프로파일

Precision Nano Systems
Genevant Sciences
Arcturus Therapeutics
Acuitas Therapeutics
Polymun Scientific
Cure Vac
e The RNA Immunotherapies
Nanovex Biotechnologies
Lipoid
Evonik Industries
Bio NTech
Daiichi Sankyo
Moderna
Sinopeg
Exelead
Nano Composix
Ionovation
Matinas Bio Pharma
Lipoid Kosmetik
Phosphorex

제9장 당사에 대해서

SHW

영문 목차

영문목차

Lipid Nanoparticles Market is anticipated to expand from $1.4 billion in 2024 to $4.3 billion by 2034, growing at a CAGR of approximately 12.6%. The Lipid Nanoparticles Market encompasses the development and application of nanoscale lipid carriers for drug delivery, particularly in mRNA vaccines and gene therapies. These nanoparticles facilitate targeted delivery and controlled release of therapeutic agents, enhancing efficacy and reducing side effects. The market is driven by advancements in nanotechnology, increasing demand for precision medicine, and the success of lipid nanoparticle-based COVID-19 vaccines, prompting further research and investment in this transformative sector.

The Lipid Nanoparticles Market is experiencing robust growth, propelled by advancements in drug delivery systems and vaccine development. The pharmaceutical segment is the top-performing sector, driven by the increasing application of lipid nanoparticles in mRNA-based therapeutics. Within this segment, vaccine delivery systems are leading, primarily due to the success of lipid nanoparticle-based COVID-19 vaccines. The oncology drug delivery sub-segment follows, benefiting from enhanced targeting capabilities and reduced side effects. The cosmetics industry is the second-highest performing segment, with lipid nanoparticles revolutionizing skincare formulations by improving ingredient stability and penetration. Personal care products, particularly anti-aging creams and sunscreens, are witnessing significant uptake. Research and development activities are intensifying, with a focus on optimizing lipid nanoparticle formulations for diverse therapeutic applications. The integration of lipid nanoparticles in gene therapy and personalized medicine is emerging as a promising opportunity, further driving market growth and innovation.

Market Segmentation
Type	Solid Lipid Nanoparticles, Nanostructured Lipid Carriers, Liposome
Product	Drug Delivery Systems, Cosmetic Formulations, Nutraceuticals, Gene Therapy Vectors
Technology	High Pressure Homogenization, Microemulsion, Solvent Evaporation, Supercritical Fluid Technology
Application	Pharmaceuticals, Cosmetics, Food and Beverages, Biotechnology
Material Type	Phospholipids, Cholesterol, Triglycerides, Fatty Acids
Process	Encapsulation, Emulsification, Lyophilization, Spray Drying
End User	Pharmaceutical Companies, Cosmetic Manufacturers, Research Institutes, Food Industry
Functionality	Controlled Release, Targeted Delivery, Bioavailability Enhancement, Stability Improvement
Solutions	Custom Formulation Development, Analytical Services, Scale-up and Manufacturing, Regulatory Consulting

The lipid nanoparticles market is characterized by a dynamic landscape with notable shifts in market share, pricing strategies, and product innovation. Key players are focusing on strategic partnerships and collaborations to enhance their product portfolios. The market is witnessing a surge in new product launches, driven by advancements in drug delivery systems and personalized medicine. Pricing remains competitive, influenced by the need for cost-effective solutions in pharmaceutical applications. The emphasis on research and development is fostering a competitive edge among top companies, propelling market growth. Competition benchmarking reveals a concentrated market with several dominant players exerting significant influence. Regulatory frameworks across regions, particularly in North America and Europe, are pivotal in shaping market dynamics. These regulations ensure safety and efficacy, impacting product approvals and market entry. The competitive landscape is marked by innovation, with companies investing in cutting-edge technologies to maintain their market positions. Strategic mergers and acquisitions are prevalent, enhancing capabilities and market reach. The market is poised for growth, driven by increasing demand in the biotechnology and pharmaceutical sectors.

Geographical Overview:

The lipid nanoparticles market is witnessing robust growth across various regions, each exhibiting unique dynamics. North America leads due to its advanced pharmaceutical industry and significant research investments. The region's focus on biotechnology and drug delivery systems further propels the market. Europe follows closely, driven by strong regulatory support and innovation in nanotechnology. The region's emphasis on sustainable healthcare solutions enhances its market position. In Asia Pacific, the market is expanding rapidly, fueled by increasing healthcare expenditures and technological advancements. Countries like China and India are emerging as key players due to their large populations and growing pharmaceutical sectors. Latin America and the Middle East & Africa present promising growth pockets. In Latin America, rising investments in healthcare infrastructure boost the market. The Middle East & Africa are recognizing the potential of lipid nanoparticles in addressing regional health challenges, fostering innovation and market expansion.

Global tariffs and geopolitical tensions are profoundly influencing the Lipid Nanoparticles Market, particularly in East Asia. Japan and South Korea, heavily reliant on raw material imports, are navigating these challenges by enhancing domestic production capabilities and fostering regional alliances. China's ambitious 'Made in China 2025' agenda propels its focus on self-sufficiency in lipid nanoparticle technology, while Taiwan leverages its advanced manufacturing prowess to maintain a competitive edge amidst US-China frictions. The global parent market, driven by biopharmaceutical innovations, is witnessing robust growth but remains vulnerable to supply chain disruptions. By 2035, strategic diversification and technological advancements will be pivotal. Concurrently, Middle East conflicts threaten to elevate energy prices, further complicating supply chain logistics and operational costs across the region.

Key Trends and Drivers:

The lipid nanoparticles market is experiencing robust growth, driven by advancements in nanotechnology and increasing demand for targeted drug delivery systems. A key trend is the integration of lipid nanoparticles in mRNA vaccines, which has been pivotal during the COVID-19 pandemic. This has accelerated research and investment in the field, with pharmaceutical companies focusing on innovative formulations and delivery mechanisms. Another significant driver is the rising prevalence of chronic diseases, necessitating effective drug delivery solutions. Lipid nanoparticles offer improved bioavailability and controlled release, making them ideal for treating various conditions. The market is also witnessing increased interest in cosmetic applications, where lipid nanoparticles enhance the delivery of active ingredients in skincare products. Furthermore, government support and funding for nanotechnology research are propelling market growth. Opportunities abound in personalized medicine, where lipid nanoparticles can be tailored for individual patient needs. Companies investing in research and development to optimize lipid nanoparticle formulations are well-positioned to capture substantial market share, as demand for efficient and precise drug delivery systems continues to rise.

Research Scope:

Estimates and forecasts the overall market size across type, application, and region.
Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

1 Executive Summary

1.1 Market Size and Forecast
1.2 Market Overview
1.3 Market Snapshot
1.4 Regional Snapshot
1.5 Strategic Recommendations
1.6 Analyst Notes

2 Market Highlights

2.1 Key Market Highlights by Type
2.2 Key Market Highlights by Product
2.3 Key Market Highlights by Technology
2.4 Key Market Highlights by Application
2.5 Key Market Highlights by Material Type
2.6 Key Market Highlights by Process
2.7 Key Market Highlights by End User
2.8 Key Market Highlights by Functionality
2.9 Key Market Highlights by Solutions

3 Market Dynamics

3.1 Macroeconomic Analysis
3.2 Market Trends
3.3 Market Drivers
3.4 Market Opportunities
3.5 Market Restraints
3.6 CAGR Growth Analysis
3.7 Impact Analysis
3.8 Emerging Markets
3.9 Technology Roadmap
3.10 Strategic Frameworks
- 3.10.1 PORTER's 5 Forces Model
- 3.10.2 ANSOFF Matrix
- 3.10.3 4P's Model
- 3.10.4 PESTEL Analysis

4 Segment Analysis

4.1 Market Size & Forecast by Type (2020-2035)
- 4.1.1 Solid Lipid Nanoparticles
- 4.1.2 Nanostructured Lipid Carriers
- 4.1.3 Liposome
4.2 Market Size & Forecast by Product (2020-2035)
- 4.2.1 Drug Delivery Systems
- 4.2.2 Cosmetic Formulations
- 4.2.3 Nutraceuticals
- 4.2.4 Gene Therapy Vectors
4.3 Market Size & Forecast by Technology (2020-2035)
- 4.3.1 High Pressure Homogenization
- 4.3.2 Microemulsion
- 4.3.3 Solvent Evaporation
- 4.3.4 Supercritical Fluid Technology
4.4 Market Size & Forecast by Application (2020-2035)
- 4.4.1 Pharmaceuticals
- 4.4.2 Cosmetics
- 4.4.3 Food and Beverages
- 4.4.4 Biotechnology
4.5 Market Size & Forecast by Material Type (2020-2035)
- 4.5.1 Phospholipids
- 4.5.2 Cholesterol
- 4.5.3 Triglycerides
- 4.5.4 Fatty Acids
4.6 Market Size & Forecast by Process (2020-2035)
- 4.6.1 Encapsulation
- 4.6.2 Emulsification
- 4.6.3 Lyophilization
- 4.6.4 Spray Drying
4.7 Market Size & Forecast by End User (2020-2035)
- 4.7.1 Pharmaceutical Companies
- 4.7.2 Cosmetic Manufacturers
- 4.7.3 Research Institutes
- 4.7.4 Food Industry
4.8 Market Size & Forecast by Functionality (2020-2035)
- 4.8.1 Controlled Release
- 4.8.2 Targeted Delivery
- 4.8.3 Bioavailability Enhancement
- 4.8.4 Stability Improvement
4.9 Market Size & Forecast by Solutions (2020-2035)
- 4.9.1 Custom Formulation Development
- 4.9.2 Analytical Services
- 4.9.3 Scale-up and Manufacturing
- 4.9.4 Regulatory Consulting

5 Regional Analysis

5.1 Global Market Overview
5.2 North America Market Size (2020-2035)
- 5.2.1 United States
  - 5.2.1.1 Type
  - 5.2.1.2 Product
  - 5.2.1.3 Technology
  - 5.2.1.4 Application
  - 5.2.1.5 Material Type
  - 5.2.1.6 Process
  - 5.2.1.7 End User
  - 5.2.1.8 Functionality
  - 5.2.1.9 Solutions
- 5.2.2 Canada
  - 5.2.2.1 Type
  - 5.2.2.2 Product
  - 5.2.2.3 Technology
  - 5.2.2.4 Application
  - 5.2.2.5 Material Type
  - 5.2.2.6 Process
  - 5.2.2.7 End User
  - 5.2.2.8 Functionality
  - 5.2.2.9 Solutions
- 5.2.3 Mexico
  - 5.2.3.1 Type
  - 5.2.3.2 Product
  - 5.2.3.3 Technology
  - 5.2.3.4 Application
  - 5.2.3.5 Material Type
  - 5.2.3.6 Process
  - 5.2.3.7 End User
  - 5.2.3.8 Functionality
  - 5.2.3.9 Solutions
5.3 Latin America Market Size (2020-2035)
- 5.3.1 Brazil
  - 5.3.1.1 Type
  - 5.3.1.2 Product
  - 5.3.1.3 Technology
  - 5.3.1.4 Application
  - 5.3.1.5 Material Type
  - 5.3.1.6 Process
  - 5.3.1.7 End User
  - 5.3.1.8 Functionality
  - 5.3.1.9 Solutions
- 5.3.2 Argentina
  - 5.3.2.1 Type
  - 5.3.2.2 Product
  - 5.3.2.3 Technology
  - 5.3.2.4 Application
  - 5.3.2.5 Material Type
  - 5.3.2.6 Process
  - 5.3.2.7 End User
  - 5.3.2.8 Functionality
  - 5.3.2.9 Solutions
- 5.3.3 Rest of Latin America
  - 5.3.3.1 Type
  - 5.3.3.2 Product
  - 5.3.3.3 Technology
  - 5.3.3.4 Application
  - 5.3.3.5 Material Type
  - 5.3.3.6 Process
  - 5.3.3.7 End User
  - 5.3.3.8 Functionality
  - 5.3.3.9 Solutions
5.4 Asia-Pacific Market Size (2020-2035)
- 5.4.1 China
  - 5.4.1.1 Type
  - 5.4.1.2 Product
  - 5.4.1.3 Technology
  - 5.4.1.4 Application
  - 5.4.1.5 Material Type
  - 5.4.1.6 Process
  - 5.4.1.7 End User
  - 5.4.1.8 Functionality
  - 5.4.1.9 Solutions
- 5.4.2 India
  - 5.4.2.1 Type
  - 5.4.2.2 Product
  - 5.4.2.3 Technology
  - 5.4.2.4 Application
  - 5.4.2.5 Material Type
  - 5.4.2.6 Process
  - 5.4.2.7 End User
  - 5.4.2.8 Functionality
  - 5.4.2.9 Solutions
- 5.4.3 South Korea
  - 5.4.3.1 Type
  - 5.4.3.2 Product
  - 5.4.3.3 Technology
  - 5.4.3.4 Application
  - 5.4.3.5 Material Type
  - 5.4.3.6 Process
  - 5.4.3.7 End User
  - 5.4.3.8 Functionality
  - 5.4.3.9 Solutions
- 5.4.4 Japan
  - 5.4.4.1 Type
  - 5.4.4.2 Product
  - 5.4.4.3 Technology
  - 5.4.4.4 Application
  - 5.4.4.5 Material Type
  - 5.4.4.6 Process
  - 5.4.4.7 End User
  - 5.4.4.8 Functionality
  - 5.4.4.9 Solutions
- 5.4.5 Australia
  - 5.4.5.1 Type
  - 5.4.5.2 Product
  - 5.4.5.3 Technology
  - 5.4.5.4 Application
  - 5.4.5.5 Material Type
  - 5.4.5.6 Process
  - 5.4.5.7 End User
  - 5.4.5.8 Functionality
  - 5.4.5.9 Solutions
- 5.4.6 Taiwan
  - 5.4.6.1 Type
  - 5.4.6.2 Product
  - 5.4.6.3 Technology
  - 5.4.6.4 Application
  - 5.4.6.5 Material Type
  - 5.4.6.6 Process
  - 5.4.6.7 End User
  - 5.4.6.8 Functionality
  - 5.4.6.9 Solutions
- 5.4.7 Rest of APAC
  - 5.4.7.1 Type
  - 5.4.7.2 Product
  - 5.4.7.3 Technology
  - 5.4.7.4 Application
  - 5.4.7.5 Material Type
  - 5.4.7.6 Process
  - 5.4.7.7 End User
  - 5.4.7.8 Functionality
  - 5.4.7.9 Solutions
5.5 Europe Market Size (2020-2035)
- 5.5.1 Germany
  - 5.5.1.1 Type
  - 5.5.1.2 Product
  - 5.5.1.3 Technology
  - 5.5.1.4 Application
  - 5.5.1.5 Material Type
  - 5.5.1.6 Process
  - 5.5.1.7 End User
  - 5.5.1.8 Functionality
  - 5.5.1.9 Solutions
- 5.5.2 France
  - 5.5.2.1 Type
  - 5.5.2.2 Product
  - 5.5.2.3 Technology
  - 5.5.2.4 Application
  - 5.5.2.5 Material Type
  - 5.5.2.6 Process
  - 5.5.2.7 End User
  - 5.5.2.8 Functionality
  - 5.5.2.9 Solutions
- 5.5.3 United Kingdom
  - 5.5.3.1 Type
  - 5.5.3.2 Product
  - 5.5.3.3 Technology
  - 5.5.3.4 Application
  - 5.5.3.5 Material Type
  - 5.5.3.6 Process
  - 5.5.3.7 End User
  - 5.5.3.8 Functionality
  - 5.5.3.9 Solutions
- 5.5.4 Spain
  - 5.5.4.1 Type
  - 5.5.4.2 Product
  - 5.5.4.3 Technology
  - 5.5.4.4 Application
  - 5.5.4.5 Material Type
  - 5.5.4.6 Process
  - 5.5.4.7 End User
  - 5.5.4.8 Functionality
  - 5.5.4.9 Solutions
- 5.5.5 Italy
  - 5.5.5.1 Type
  - 5.5.5.2 Product
  - 5.5.5.3 Technology
  - 5.5.5.4 Application
  - 5.5.5.5 Material Type
  - 5.5.5.6 Process
  - 5.5.5.7 End User
  - 5.5.5.8 Functionality
  - 5.5.5.9 Solutions
- 5.5.6 Rest of Europe
  - 5.5.6.1 Type
  - 5.5.6.2 Product
  - 5.5.6.3 Technology
  - 5.5.6.4 Application
  - 5.5.6.5 Material Type
  - 5.5.6.6 Process
  - 5.5.6.7 End User
  - 5.5.6.8 Functionality
  - 5.5.6.9 Solutions
5.6 Middle East & Africa Market Size (2020-2035)
- 5.6.1 Saudi Arabia
  - 5.6.1.1 Type
  - 5.6.1.2 Product
  - 5.6.1.3 Technology
  - 5.6.1.4 Application
  - 5.6.1.5 Material Type
  - 5.6.1.6 Process
  - 5.6.1.7 End User
  - 5.6.1.8 Functionality
  - 5.6.1.9 Solutions
- 5.6.2 United Arab Emirates
  - 5.6.2.1 Type
  - 5.6.2.2 Product
  - 5.6.2.3 Technology
  - 5.6.2.4 Application
  - 5.6.2.5 Material Type
  - 5.6.2.6 Process
  - 5.6.2.7 End User
  - 5.6.2.8 Functionality
  - 5.6.2.9 Solutions
- 5.6.3 South Africa
  - 5.6.3.1 Type
  - 5.6.3.2 Product
  - 5.6.3.3 Technology
  - 5.6.3.4 Application
  - 5.6.3.5 Material Type
  - 5.6.3.6 Process
  - 5.6.3.7 End User
  - 5.6.3.8 Functionality
  - 5.6.3.9 Solutions
- 5.6.4 Sub-Saharan Africa
  - 5.6.4.1 Type
  - 5.6.4.2 Product
  - 5.6.4.3 Technology
  - 5.6.4.4 Application
  - 5.6.4.5 Material Type
  - 5.6.4.6 Process
  - 5.6.4.7 End User
  - 5.6.4.8 Functionality
  - 5.6.4.9 Solutions
- 5.6.5 Rest of MEA
  - 5.6.5.1 Type
  - 5.6.5.2 Product
  - 5.6.5.3 Technology
  - 5.6.5.4 Application
  - 5.6.5.5 Material Type
  - 5.6.5.6 Process
  - 5.6.5.7 End User
  - 5.6.5.8 Functionality
  - 5.6.5.9 Solutions

6 Market Strategy

6.1 Demand-Supply Gap Analysis
6.2 Trade & Logistics Constraints
6.3 Price-Cost-Margin Trends
6.4 Market Penetration
6.5 Consumer Analysis
6.6 Regulatory Snapshot

7 Competitive Intelligence

7.1 Market Positioning
7.2 Market Share
7.3 Competition Benchmarking
7.4 Top Company Strategies

8 Company Profiles

8.1 Precision Nano Systems
- 8.1.1 Overview
- 8.1.2 Product Summary
- 8.1.3 Financial Performance
- 8.1.4 SWOT Analysis
8.2 Genevant Sciences
- 8.2.1 Overview
- 8.2.2 Product Summary
- 8.2.3 Financial Performance
- 8.2.4 SWOT Analysis
8.3 Arcturus Therapeutics
- 8.3.1 Overview
- 8.3.2 Product Summary
- 8.3.3 Financial Performance
- 8.3.4 SWOT Analysis
8.4 Acuitas Therapeutics
- 8.4.1 Overview
- 8.4.2 Product Summary
- 8.4.3 Financial Performance
- 8.4.4 SWOT Analysis
8.5 Polymun Scientific
- 8.5.1 Overview
- 8.5.2 Product Summary
- 8.5.3 Financial Performance
- 8.5.4 SWOT Analysis
8.6 Cure Vac
- 8.6.1 Overview
- 8.6.2 Product Summary
- 8.6.3 Financial Performance
- 8.6.4 SWOT Analysis
8.7 e The RNA Immunotherapies
- 8.7.1 Overview
- 8.7.2 Product Summary
- 8.7.3 Financial Performance
- 8.7.4 SWOT Analysis
8.8 Nanovex Biotechnologies
- 8.8.1 Overview
- 8.8.2 Product Summary
- 8.8.3 Financial Performance
- 8.8.4 SWOT Analysis
8.9 Lipoid
- 8.9.1 Overview
- 8.9.2 Product Summary
- 8.9.3 Financial Performance
- 8.9.4 SWOT Analysis
8.10 Evonik Industries
- 8.10.1 Overview
- 8.10.2 Product Summary
- 8.10.3 Financial Performance
- 8.10.4 SWOT Analysis
8.11 Bio NTech
- 8.11.1 Overview
- 8.11.2 Product Summary
- 8.11.3 Financial Performance
- 8.11.4 SWOT Analysis
8.12 Daiichi Sankyo
- 8.12.1 Overview
- 8.12.2 Product Summary
- 8.12.3 Financial Performance
- 8.12.4 SWOT Analysis
8.13 Moderna
- 8.13.1 Overview
- 8.13.2 Product Summary
- 8.13.3 Financial Performance
- 8.13.4 SWOT Analysis
8.14 Sinopeg
- 8.14.1 Overview
- 8.14.2 Product Summary
- 8.14.3 Financial Performance
- 8.14.4 SWOT Analysis
8.15 Exelead
- 8.15.1 Overview
- 8.15.2 Product Summary
- 8.15.3 Financial Performance
- 8.15.4 SWOT Analysis
8.16 Nano Composix
- 8.16.1 Overview
- 8.16.2 Product Summary
- 8.16.3 Financial Performance
- 8.16.4 SWOT Analysis
8.17 Ionovation
- 8.17.1 Overview
- 8.17.2 Product Summary
- 8.17.3 Financial Performance
- 8.17.4 SWOT Analysis
8.18 Matinas Bio Pharma
- 8.18.1 Overview
- 8.18.2 Product Summary
- 8.18.3 Financial Performance
- 8.18.4 SWOT Analysis
8.19 Lipoid Kosmetik
- 8.19.1 Overview
- 8.19.2 Product Summary
- 8.19.3 Financial Performance
- 8.19.4 SWOT Analysis
8.20 Phosphorex
- 8.20.1 Overview
- 8.20.2 Product Summary
- 8.20.3 Financial Performance
- 8.20.4 SWOT Analysis

9 About Us

9.1 About Us
9.2 Research Methodology
9.3 Research Workflow
9.4 Consulting Services
9.5 Our Clients
9.6 Client Testimonials
9.7 Contact Us